Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells;Journal for ImmunoTherapy of Cancer;(2019) 7:231;2019.8.20

Publisher：Dates：2019-08-20Views：